Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ANGIOCOMB Antiangiogenic Therapy for Pediatric Patients With Diffuse Brain Stem and Thalamic Tumors

NCT01756989 is registered in ClinicalTrials.gov with Helsinki University Central Hospital as lead sponsor.

NCT NCT01756989
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01756989 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ANGIOCOMB Antiangiogenic Therapy for Pediatric Patients With Diffuse Brain Stem and Thalamic Tumors
Lead sponsor
Helsinki University Central Hospital
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2005
Completion date
December 31, 2013
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brainstem glioma